Works by Yamanaka, Takeharu


Results: 123
    1
    2
    3
    4
    5
    6

    Randomized controlled trial of landiolol, a short-acting beta-1 adrenergic receptor blocker, illustrating changes in high-molecular weight adiponectin levels after elective percutaneous coronary intervention.

    Published in:
    Heart & Vessels, 2020, v. 35, n. 11, p. 1510, doi. 10.1007/s00380-020-01637-6
    By:
    • Kiyokuni, Masayoshi;
    • Konishi, Masaaki;
    • Saigusa, Yusuke;
    • Iwata, Kiwamu;
    • Nakayama, Naoki;
    • Komura, Naohiro;
    • Sugano, Teruyasu;
    • Ishigami, Tomoaki;
    • Ishikawa, Toshiyuki;
    • Yamanaka, Takeharu;
    • Tamura, Kouichi;
    • Kimura, Kazuo
    Publication type:
    Article
    7
    8
    9
    10

    Multicenter, randomized, controlled trial of S‐1 monotherapy versus S‐1 and interferon‐α combination therapy for hepatocellular carcinoma with extrahepatic metastases.

    Published in:
    Hepatology Research, 2018, v. 48, n. 9, p. 717, doi. 10.1111/hepr.13067
    By:
    • Nagano, Hiroaki;
    • Obi, Shuntaro;
    • Hatano, Etsuro;
    • Kaneko, Shuichi;
    • Kanai, Fumihiko;
    • Omata, Masao;
    • Tsuji, Akihito;
    • Itamoto, Toshiyuki;
    • Yamamoto, Kazuhide;
    • Tanaka, Masatoshi;
    • Kubo, Shoji;
    • Hirata, Koichi;
    • Nakamura, Hideji;
    • Tomimaru, Yoshito;
    • Yamanaka, Takeharu;
    • Kojima, Shinsuke;
    • Monden, Morito
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Randomised phase II trial of mFOLFOX6 plus bevacizumab versus mFOLFOX6 plus cetuximab as first-line treatment for colorectal liver metastasis (ATOM trial).

    Published in:
    2019
    By:
    • Oki, Eiji;
    • Emi, Yasunori;
    • Yamanaka, Takeharu;
    • Uetake, Hiroyuki;
    • Muro, Kei;
    • Takahashi, Takao;
    • Nagasaka, Takeshi;
    • Hatano, Etsuro;
    • Ojima, Hitoshi;
    • Manaka, Dai;
    • Kusumoto, Tetsuya;
    • Katayose, Yu;
    • Fujiwara, Toshiyoshi;
    • Yoshida, Kazuhiro;
    • Unno, Michiaki;
    • Hyodo, Ichinosuke;
    • Tomita, Naohiro;
    • Sugihara, Kenichi;
    • Maehara, Yoshihiko
    Publication type:
    journal article
    23
    24

    Phase III randomised trial comparing 6 vs. 12-month of capecitabine as adjuvant chemotherapy for patients with stage III colon cancer: final results of the JFMC37-0801 study.

    Published in:
    2019
    By:
    • Tomita, Naohiro;
    • Kunieda, Katsuyuki;
    • Maeda, Atsuyuki;
    • Hamada, Chikuma;
    • Yamanaka, Takeharu;
    • Sato, Toshihiko;
    • Yoshida, Kazuhiro;
    • Boku, Narikazu;
    • Nezu, Riichiro;
    • Yamaguchi, Shigeki;
    • Mishima, Hideyuki;
    • Sadahiro, Sotaro;
    • Muro, Kei;
    • Ishiguro, Megumi;
    • Sakamoto, Junichi;
    • Saji, Shigetoyo;
    • Maehara, Yoshihiko
    Publication type:
    journal article
    25

    A randomised phase II trial of S-1 plus cisplatin versus vinorelbine plus cisplatin with concurrent thoracic radiotherapy for unresectable, locally advanced non-small cell lung cancer: WJOG5008L.

    Published in:
    2018
    By:
    • Sasaki, Tomonari;
    • Seto, Takashi;
    • Yamanaka, Takeharu;
    • Kunitake, Naonobu;
    • Shimizu, Junichi;
    • Kodaira, Takeshi;
    • Nishio, Makoto;
    • Kozuka, Takuyo;
    • Takahashi, Toshiaki;
    • Harada, Hideyuki;
    • Yoshimura, Naruo;
    • Tsutsumi, Shinichi;
    • Kitajima, Hiromoto;
    • Kataoka, Masaaki;
    • Ichinose, Yukito;
    • Nakagawa, Kazuhiko;
    • Nishimura, Yasumasa;
    • Yamamoto, Nobuyuki;
    • Nakanishi, Yoichi
    Publication type:
    journal article
    26

    Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive Cancer genomics (BREAC) study.

    Published in:
    2017
    By:
    • Shinozaki, Eiji;
    • Yoshino, Takayuki;
    • Yamazaki, Kentaro;
    • Muro, Kei;
    • Yamaguchi, Kensei;
    • Nishina, Tomohiro;
    • Yuki, Satoshi;
    • Shitara, Kohei;
    • Bando, Hideaki;
    • Mimaki, Sachiyo;
    • Nakai, Chikako;
    • Matsushima, Koutatsu;
    • Suzuki, Yutaka;
    • Akagi, Kiwamu;
    • Yamanaka, Takeharu;
    • Nomura, Shogo;
    • Fujii, Satoshi;
    • Esumi, Hiroyasu;
    • Sugiyama, Masaya;
    • Nishida, Nao
    Publication type:
    journal article
    27
    28
    29
    30
    31

    Short-Term Outcomes from a Randomized Screening Phase II Non-inferiority Trial Comparing Omentectomy and Omentum Preservation for Locally Advanced Gastric Cancer: the TOP-G Trial.

    Published in:
    World Journal of Surgery, 2021, v. 45, n. 6, p. 1803, doi. 10.1007/s00268-021-05988-7
    By:
    • Murakami, Hitoshi;
    • Yamada, Takanobu;
    • Taguri, Masataka;
    • Hasegawa, Shinichi;
    • Yamanaka, Takeharu;
    • Rino, Yasushi;
    • Mushiake, Hiroyuki;
    • Oshima, Takashi;
    • Matsukawa, Hiroshi;
    • Tani, Kazuyuki;
    • Suzuki, Yoshihiro;
    • Ozawa, Yukihiro;
    • Tanabe, Hiroyasu;
    • Osaragi, Tomohiko;
    • Sato, Tsutomu;
    • Tamagawa, Hiroshi;
    • Yukawa, Norio;
    • Yoshikawa, Takaki;
    • Imada, Toshio;
    • Masuda, Munetaka
    Publication type:
    Article
    32
    33
    34

    Portal Vein Thrombosis After Hepatectomy.

    Published in:
    World Journal of Surgery, 2014, v. 38, n. 6, p. 1491, doi. 10.1007/s00268-013-2440-8
    By:
    • Yoshiya, Shohei;
    • Shirabe, Ken;
    • Nakagawara, Hidekazu;
    • Soejima, Yuji;
    • Yoshizumi, Tomoharu;
    • Ikegami, Toru;
    • Yamashita, Yo-ichi;
    • Harimoto, Norifumi;
    • Nishie, Akihiro;
    • Yamanaka, Takeharu;
    • Maehara, Yoshihiko
    Publication type:
    Article
    35
    36
    37
    38

    A Multicenter Clinical Phase II Study of FOLFOXIRI Plus Bevacizumab as First-line Therapy in Patients With Metastatic Colorectal Cancer: QUATTRO Study.

    Published in:
    2018
    By:
    • Eiji Oki;
    • Takeshi Kato;
    • Hideaki Bando;
    • Takayuki Yoshino;
    • Kei Muro;
    • Hiroya Taniguchi;
    • Yoshinori Kagawa;
    • Kentaro Yamazaki;
    • Tatsuro Yamaguchi;
    • Akihito Tsuji;
    • Shigeyoshi Iwamoto;
    • Goro Nakayama;
    • Yasunori Emi;
    • Tetsuo Touyama;
    • Masato Nakamura;
    • Masahito Kotaka;
    • Hideki Sakisaka;
    • Takeharu Yamanaka;
    • Akiyoshi Kanazawa;
    • Oki, Eiji
    Publication type:
    journal article
    39

    Rationale for and Design of the PARADIGM Study: Randomized Phase III Study of mFOLFOX6 Plus Bevacizumab or Panitumumab in Chemotherapy-naïve Patients With RAS (KRAS/NRAS) Wild-type, Metastatic Colorectal Cancer.

    Published in:
    2017
    By:
    • Takayuki Yoshino;
    • Hiroyuki Uetake;
    • Katsuya Tsuchihara;
    • Kohei Shitara;
    • Kentaro Yamazaki;
    • Eiji Oki;
    • Takeo Sato;
    • Takeshi Naitoh;
    • Yoshito Komatsu;
    • Takeshi Kato;
    • Kazunori Yamanaka;
    • Kouji Iwasaki;
    • Jumpei Soeda;
    • Masamitsu Hihara;
    • Takeharu Yamanaka;
    • Atsushi Ochiai;
    • Kei Muro;
    • Yoshino, Takayuki;
    • Uetake, Hiroyuki;
    • Tsuchihara, Katsuya
    Publication type:
    journal article
    40

    Validation of tissue factor pathway inhibitor 2 as a specific biomarker for preoperative prediction of clear cell carcinoma of the ovary.

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 7, p. 1336, doi. 10.1007/s10147-021-01914-y
    By:
    • Miyagi, Etsuko;
    • Arakawa, Noriaki;
    • Sakamaki, Kentaro;
    • Yokota, Naho Ruiz;
    • Yamanaka, Takeharu;
    • Yamada, Yuki;
    • Yamaguchi, Satoshi;
    • Nagao, Shoji;
    • Hirashima, Yasuyuki;
    • Kasamatsu, Yuka;
    • Kato, Hisamori;
    • Mogami, Tae;
    • Miyagi, Yohei;
    • Kobayashi, Hiroshi
    Publication type:
    Article
    41

    Evaluation of FOLFOX or CAPOX reintroduction with or without bevacizumab in relapsed colorectal cancer patients treated with oxaliplatin as adjuvant chemotherapy (REACT study).

    Published in:
    International Journal of Clinical Oncology, 2020, v. 25, n. 8, p. 1515, doi. 10.1007/s10147-020-01701-1
    By:
    • Kotaka, Masahito;
    • Iwamoto, Shigeyoshi;
    • Satake, Hironaga;
    • Sakai, Daisuke;
    • Kudo, Toshihiro;
    • Fukunaga, Mutsumi;
    • Konishi, Ken;
    • Ide, Yoshihito;
    • Ikumoto, Taro;
    • Tsuji, Akihito;
    • Sano, Yasushi;
    • Kato, Takeshi;
    • Sugimoto, Naotoshi;
    • Satoh, Taroh;
    • Kanazawa, Akiyoshi;
    • Kurata, Takayasu;
    • Yamanaka, Takeharu;
    • Tomita, Naohiro
    Publication type:
    Article
    42

    Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial)

    Published in:
    International Journal of Clinical Oncology, 2016, v. 21, n. 3, p. 523, doi. 10.1007/s10147-015-0925-1
    By:
    • Hasegawa, Seiki;
    • Okada, Morihito;
    • Tanaka, Fumihiro;
    • Yamanaka, Takeharu;
    • Soejima, Toshinori;
    • Kamikonya, Norihiko;
    • Tsujimura, Tohru;
    • Fukuoka, Kazuya;
    • Yokoi, Kohei;
    • Nakano, Takashi
    Publication type:
    Article
    43

    Preventive effect of Goshajinkigan on peripheral neurotoxicity of FOLFOX therapy (GENIUS trial): a placebo-controlled, double-blind, randomized phase III study.

    Published in:
    International Journal of Clinical Oncology, 2015, v. 20, n. 4, p. 767, doi. 10.1007/s10147-015-0784-9
    By:
    • Oki, Eiji;
    • Emi, Yasunori;
    • Kojima, Hiroshi;
    • Higashijima, Jun;
    • Kato, Takeshi;
    • Miyake, Yasuhiro;
    • Kon, Masanori;
    • Ogata, Yutaka;
    • Takahashi, Kenichi;
    • Ishida, Hideyuki;
    • Saeki, Hiroshi;
    • Sakaguchi, Yoshihisa;
    • Yamanaka, Takeharu;
    • Kono, Toru;
    • Tomita, Naohiro;
    • Baba, Hideo;
    • Shirabe, Ken;
    • Kakeji, Yoshihiro;
    • Maehara, Yoshihiko
    Publication type:
    Article
    44

    Evaluating the 21-gene assay Recurrence Score as a predictor of clinical response to 24 weeks of neoadjuvant exemestane in estrogen receptor-positive breast cancer.

    Published in:
    International Journal of Clinical Oncology, 2014, v. 19, n. 4, p. 607, doi. 10.1007/s10147-013-0614-x
    By:
    • Ueno, Takayuki;
    • Masuda, Norikazu;
    • Yamanaka, Takeharu;
    • Saji, Shigehira;
    • Kuroi, Katsumasa;
    • Sato, Nobuaki;
    • Takei, Hiroyuki;
    • Yamamoto, Yutaka;
    • Ohno, Shinji;
    • Yamashita, Hiroko;
    • Hisamatsu, Kazufumi;
    • Aogi, Kenjiro;
    • Iwata, Hiroji;
    • Sasano, Hironobu;
    • Toi, Masakazu
    Publication type:
    Article
    45

    Plasma high-mobility group box 1 as an indicator of surgical stress.

    Published in:
    Surgery Today, 2011, v. 41, n. 7, p. 903, doi. 10.1007/s00595-010-4371-4
    By:
    • Osoegawa, Atsushi;
    • Yano, Tokujiro;
    • Yamanaka, Takeharu;
    • Tagawa, Tetsuzo;
    • Shoji, Fumihiro;
    • Yoshino, Ichiro;
    • Taketomi, Akinobu;
    • Ito, Hiroyuki;
    • Kakeji, Yoshihiro;
    • Maehara, Yoshihiko
    Publication type:
    Article
    46
    47
    48
    49
    50